MTX-211

SKU: orb1302976

Description

MTX-211 is a dual inhibitor targeting EGFR and PI3K, utilized in cancer research. It has demonstrated activity in both in vitro cell-based assays and in vivo tumor models, supporting its investigation in oncology and related disease pathways.

Research Area

Cardiovascular Research, Signal Transduction

Key Properties

• CAS Number: 1952236-05-3
• MW: 478.33
• Purity: >99.99% (May vary between batches)
• Formula: C₂₀H₁₄Cl₂FN₅O₂S
• SMILES: CS(=O)(=O)Nc1cc(cnc1Cl)-c1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1
• Target: PI3K,EGFR
• Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.09 mM);DMSO:15 mg/mL (31.36 mM)

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

cancer, MTX 211, MTX211, MTX-211, inhibit, Mol 211, Mol211, Mol-211, Epidermal growth factor receptor, ErbB-1, EGFR, Inhibitor, HER1, PI3K, phosphoinositide 3 ' OH kinase family (PIK3), Phosphoinositide 3-kinase, quinazoline derivatives, the epidermal growth factor EGFR family

Compound Identifiers

PubChem CID

121416213